An anti-tuberculosis compound screen using a zebrafish infection model identifies an aspartyl-tRNA synthetase inhibitorEva Habjan, Alexander Speer, Vien Q. T. Ho et al.|Disease Models & Mechanisms|2021Cited by 29
A dominant activating RAC2 variant associated with immunodeficiency and pulmonary diseaseBas M. Smits, Marianne Boes, Helen L. Leavis et al.|Clinical Immunology|2019Cited by 28
Engineering a self-sufficient Mycobacterium tuberculosis CYP130 by gene fusion with the reductase-domain of CYP102A1 from Bacillus megateriumSandra Ortega Ugalde, Jan N. M. Commandeur, Wilbert Bitter et al.|Journal of Inorganic Biochemistry|2017Cited by 11